NCT02068508 Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment" Status COMPLETED Phase N/A
NCT02068443 Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy Status COMPLETED Phase PHASE3
NCT02065544 Remission Rates of New Type 2 Diabetes With Weight Loss and Exercise Status COMPLETED Phase NA
NCT02060201 Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC) Status COMPLETED Phase PHASE1
NCT02059187 The Safety and Efficacy of MK-1293 Versus Lantus™ in Participants With Type 2 Diabetes Mellitus (MK-1293-006) Status COMPLETED Phase PHASE3
NCT02055547 A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002) Status COMPLETED Phase PHASE1
NCT02054650 OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus Status TERMINATED Phase NA
NCT02053116 A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin Status TERMINATED Phase PHASE2
NCT02053103 A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin Status TERMINATED Phase PHASE2
NCT02049814 Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT02043054 Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA) Status COMPLETED Phase PHASE3
NCT02040012 A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus Status UNKNOWN Phase PHASE1
NCT02036515 Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2) Status COMPLETED Phase PHASE3
NCT02033889 A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007). Status COMPLETED Phase PHASE3
NCT02033876 Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin Status COMPLETED Phase PHASE2
NCT02031341 Peripheral Insulin Uptake in Type 2 Diabetes Mellitus and in Non-Diabetic Individuals Status COMPLETED Phase N/A
NCT02027103 Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes Patients Status COMPLETED Phase NA